Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Range Resources
RRC
$9.33B
| $8.2M | ﹤0.01% |
269,334
-155,521
| -37% | -$5.1M |
|
702
lululemon athletica
LULU
$13.5B
| $8.15M | ﹤0.01% |
15,928
+3,358
| +27% | +$1.45M |
|
703
AerCap
AER
$23.4B
| $8.08M | ﹤0.01% |
108,687
+20,500
| +23% | +$1.35M |
|
|
ANSS
704
DELISTED
Ansys
ANSS
| $8.03M | ﹤0.01% |
22,128
+9,242
| +72% | +$2.74M |
|
705
Louisiana-Pacific
LPX
$5.14B
| $7.93M | ﹤0.01% |
111,932
-109,307
| -49% | -$6.53M |
|
706
Adtran
ADTN
$675M
| $7.89M | ﹤0.01% |
1,046,251
-230,931
| -18% | -$1.52M |
|
707
Kinder Morgan
KMI
$70.9B
| $7.81M | ﹤0.01% |
442,869
+164,561
| +59% | +$2.8M |
|
|
ABVX
708
Abivax
ABVX
$10.4B
| $7.72M | ﹤0.01% |
+720,425
| New | +$7.34M |
|
709
Alpha Metallurgical Resources
AMR
$1.77B
| $7.72M | ﹤0.01% |
22,787
+4,226
| +23% | +$1.11M |
|
710
Electronic Arts
EA
$52.7B
| $7.71M | ﹤0.01% |
56,336
-186
| -0.3% | -$24.6K |
|
711
Airbnb
ABNB
$90.8B
| $7.69M | ﹤0.01% |
56,440
-562
| -1% | -$72.5K |
|
712
Otis Worldwide
OTIS
$27.9B
| $7.66M | ﹤0.01% |
85,545
+4,257
| +5% | +$354K |
|
713
Enbridge
ENB
$120B
| $7.64M | ﹤0.01% |
211,229
+900
| +0.4% | +$30.3K |
|
714
TransDigm Group
TDG
$70.7B
| $7.62M | ﹤0.01% |
7,530
-4,858
| -39% | -$4.48M |
|
715
Coeur Mining
CDE
$15.1B
| $7.48M | ﹤0.01% |
2,298,350
+798,629
| +53% | +$2.18M |
|
716
Allstate
ALL
$70.6B
| $7.43M | ﹤0.01% |
53,058
-964
| -2% | -$126K |
|
717
Immatics
IMTX
$1.23B
| $7.42M | ﹤0.01% |
+704,391
| New | +$6.48M |
|
718
Fastenal
FAST
$54.8B
| $7.38M | ﹤0.01% |
227,814
+72,468
| +47% | +$2.18M |
|
719
Norfolk Southern
NSC
$75.4B
| $7.37M | ﹤0.01% |
31,164
-12,236
| -28% | -$2.56M |
|
720
Bunge Global
BG
$20.9B
| $7.31M | ﹤0.01% |
72,388
-56,422
| -44% | -$5.91M |
|
|
APLT
721
DELISTED
Applied Therapeutics
APLT
| $7.19M | ﹤0.01% |
+2,148,463
| New | +$5.35M |
|
722
QuidelOrtho
QDEL
$1.13B
| $7.18M | ﹤0.01% |
97,471
-456,679
| -82% | -$30.9M |
|
723
Idexx Laboratories
IDXX
$44.9B
| $7.17M | ﹤0.01% |
12,906
+135
| +1% | +$63.4K |
|
724
Liberty Global Class A
LBTYA
$3.59B
| $7.15M | ﹤0.01% |
402,687
-17,199
| -4% | -$279K |
|
|
EPIX
725
DELISTED
ESSA Pharma
EPIX
| $7.13M | ﹤0.01% |
+1,089,482
| New | +$5.37M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.